Home » Market News » DirectorsTalk Highlights » BioSpace Global Roundup
Avacta Group Plc

BioSpace Global Roundup

South Korea-based LG Chem Life Sciences and U.K.-based Avacta Group have moved forward in their Affimer therapeutics partnership. Avacta has successfully generated a large number of Affimer proteins that bind to the first drug target nominated by LG Chem. These candidate Affimer molecules are now being optimized by Avacta, for LG Chem to then carry out preclinical development.

If successful, it will trigger the next milestone payment to Avacta from LG Chem. 

Avacta Group Plc (LON:AVCT) offers reagents and therapeutics based on Affimer technology for diagnostic and research applications in the United Kingdom. The company’s custom Affimer products are also used in drugs and biomarkers discovery in biotech research and development.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.